Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ARICEPT 5 MG

DONEPEZIL HYDROCHLORIDE : 5 MG · DIN 02232043 · PFIZER CANADA ULC

Health Canada status: MARKETED

What is ARICEPT?

ARICEPT 5 MG contains DONEPEZIL HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02232043, held by PFIZER CANADA ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 20-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is ARICEPT used for?

ARICEPT (donepezil hydrochloride) is indicated for symptomatic treatment of patients with mild, moderate and severe dementia of the Alzheimer’s type. Efficacy of ARICEPT in patients with mild to moderate Alzheimer’s disease was established in two 24 week and one 54 - week placebo - controlled trials. Efficacy in patients with severe Alzheimer’s disease was established in three 24 - week/ 6 - month placebo - controlled trials.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

What else is ARICEPT called?

The same molecule, DONEPEZIL, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
Donepezil SandozLatinAustralia, Sweden
APO-DonepezilLatinAustralia
ArazilLatinAustralia
Donepezil AccordLatinSweden
Donepezil ActavisLatinSweden
Donepezil GHLatinAustralia
Donepezil KrkaLatinSweden
Donepezil OrionLatinSweden
Donepezil STADALatinSweden
DONEPEZIL-WGRLatinAustralia
DOPEZIL RANBAXYLatinMorocco
Donepezil JubilantLatinSweden
Donepezil ViatrisLatinSweden
ARICEPT EVESSLatinRomania

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Product details and regulatory record

DIN02232043
Brand nameARICEPT
Generic / active ingredientDONEPEZIL HYDROCHLORIDE : 5 MG
ManufacturerPFIZER CANADA ULC
Strength5 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeN06DA02 DONEPEZIL
AHFS class12:04.00
BiosimilarNo
Health Canada statusMARKETED
Status date20-Aug-1997
Original market date1997-08-20 00:00:00

How is this product identified?

Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.

DIN (8-digit, as used in Nexara ordering)02232043
DIN (unpadded, as printed on some documents)2232043
Brand nameARICEPT
Active ingredient / INNDONEPEZIL HYDROCHLORIDE : 5 MG
ATC codeN06DA02
ATC anatomical main groupN — Nervous system
ATC therapeutic subgroupN06
AHFS class12:04.00
Health Canada schedulePrescription
Biosimilar biologicNo
Market authorization holderPFIZER CANADA ULC

Health Canada approved product monograph (PDF)

How is it stored and handled?

null

How is it supplied?

HDPE bottles of 30 tablets

Which pack is which?

Strength on the label5 MG
Dosage formTABLET
RouteORAL
Packaging as described in the monographHDPE bottles of 30 tablets
Storagenull

One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Confirm the pack and get a price

Is DONEPEZIL in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANIS HEALTH INC, last seen 20 Apr 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for ARICEPT

What can be used instead?

Other Canadian products sharing ATC code N06DA02 DONEPEZIL. 37 of 76 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ACH-DONEPEZIL10 MGTABLETACCORD HEALTHCARE INCMARKETEDDIN 02402653
ACH-DONEPEZIL5 MGTABLETACCORD HEALTHCARE INCMARKETEDDIN 02402645
AG-DONEPEZIL10 MGTABLETANGITA PHARMA INC.MARKETEDDIN 02432692
AG-DONEPEZIL5 MGTABLETANGITA PHARMA INC.MARKETEDDIN 02432684
APO-DONEPEZIL10 MGTABLETAPOTEX INCMARKETEDDIN 02362279
APO-DONEPEZIL5 MGTABLETAPOTEX INCMARKETEDDIN 02362260
ARICEPT10 MGTABLETPFIZER CANADA ULCMARKETEDDIN 02232044
AURO-DONEPEZIL10 MGTABLETAURO PHARMA INCMARKETEDDIN 02400588
AURO-DONEPEZIL5 MGTABLETAURO PHARMA INCMARKETEDDIN 02400561
BIO-DONEPEZIL10 MGTABLETBIOMED PHARMAMARKETEDDIN 02412861

Who else supplies DONEPEZIL worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. DONEPEZIL appears in 512 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How much does DONEPEZIL cost around the world?

DONEPEZIL is listed on 12 national price registers Nexara tracks, across 281 pack listings published on 11 different price bases. What each country publishes is set out below.

MarketWhat that country publishesBrands listedPack listingsAs of
United Statesacquisition36203 Sep 2026
Greeceproducer price (ex-factory)555503 Sep 2026
Australiaex-manufacturer103208 Sep 2026
Italyprezzo al pubblico (classe A)123202 Sep 2026
SwedenAIP (pharmacy purchase price)83003 Sep 2026
Romaniamax producer price92503 Sep 2026
Slovakiacategorised final price101402 Sep 2026
Hungaryproducer price (ex-factory)101003 Sep 2026
South Africasingle exit price101001 Sep 2026
MoroccoPPV (public price)4805 Sep 2026
United Kingdomhospital2231 Aug 2026
Bahrainretail (max)1101 Sep 2026

Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.

Ask Nexara for a landed Canadian price

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ARICEPT

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02232043. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.